Cognaisent
Cognaisent provides machine learning software that accelerates analysis for drug discovery and molecular research. The company develops GoFish, a novel ML/deep learning AI platform built from three years of research to address limitations in current AI approaches. Its technology focuses on molecular analysis and drug discovery workflows using machine learning and deep learning models. Cognaisent operates as a B2B AI/software provider targeting pharmaceutical, biotech, and research organizations. The company is currently prototyping its flagship product prior to broader commercial deployment.
Cognaisent
Cognaisent provides machine learning software that accelerates analysis for drug discovery and molecular research. The company develops GoFish, a novel ML/deep learning AI platform built from three years of research to address limitations in current AI approaches. Its technology focuses on molecular analysis and drug discovery workflows using machine learning and deep learning models. Cognaisent operates as a B2B AI/software provider targeting pharmaceutical, biotech, and research organizations. The company is currently prototyping its flagship product prior to broader commercial deployment.